AU2018901056A0 - Optimised compounds (2) - Google Patents

Optimised compounds (2)

Info

Publication number
AU2018901056A0
AU2018901056A0 AU2018901056A AU2018901056A AU2018901056A0 AU 2018901056 A0 AU2018901056 A0 AU 2018901056A0 AU 2018901056 A AU2018901056 A AU 2018901056A AU 2018901056 A AU2018901056 A AU 2018901056A AU 2018901056 A0 AU2018901056 A0 AU 2018901056A0
Authority
AU
Australia
Prior art keywords
optimised
compounds
optimised compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2018901056A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Axelia Oncology Pty Ltd
Original Assignee
Ena Therapeutics Pty Ltd
Filing date
Publication date
Application filed by Ena Therapeutics Pty Ltd filed Critical Ena Therapeutics Pty Ltd
Publication of AU2018901056A0 publication Critical patent/AU2018901056A0/en
Priority to BR112020012360-9A priority Critical patent/BR112020012360A2/en
Priority to CA3085377A priority patent/CA3085377A1/en
Priority to EP18890144.1A priority patent/EP3728289A4/en
Priority to CN201880081904.8A priority patent/CN111491943A/en
Priority to SG11202004895UA priority patent/SG11202004895UA/en
Priority to JP2020534433A priority patent/JP7439367B2/en
Priority to AU2018391325A priority patent/AU2018391325A1/en
Priority to US16/768,341 priority patent/US20210230217A1/en
Priority to PCT/AU2018/051397 priority patent/WO2019119067A1/en
Priority to KR1020207021016A priority patent/KR20200101428A/en
Priority to IL275360A priority patent/IL275360B2/en
Priority to JP2023171495A priority patent/JP2024001114A/en
Abandoned legal-status Critical Current

Links

AU2018901056A 2017-12-21 2018-03-29 Optimised compounds (2) Abandoned AU2018901056A0 (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
IL275360A IL275360B2 (en) 2017-12-21 2018-12-21 Optimised compounds
SG11202004895UA SG11202004895UA (en) 2017-12-21 2018-12-21 Optimised compounds
CA3085377A CA3085377A1 (en) 2017-12-21 2018-12-21 Optimised compounds
EP18890144.1A EP3728289A4 (en) 2017-12-21 2018-12-21 Optimised compounds
CN201880081904.8A CN111491943A (en) 2017-12-21 2018-12-21 Optimized compounds
BR112020012360-9A BR112020012360A2 (en) 2017-12-21 2018-12-21 optimized compounds
JP2020534433A JP7439367B2 (en) 2017-12-21 2018-12-21 Optimized compound
AU2018391325A AU2018391325A1 (en) 2017-12-21 2018-12-21 Optimised compounds
US16/768,341 US20210230217A1 (en) 2017-12-21 2018-12-21 Optimised compounds
PCT/AU2018/051397 WO2019119067A1 (en) 2017-12-21 2018-12-21 Optimised compounds
KR1020207021016A KR20200101428A (en) 2017-12-21 2018-12-21 Optimized compound
JP2023171495A JP2024001114A (en) 2017-12-21 2023-10-02 Optimized compound

Publications (1)

Publication Number Publication Date
AU2018901056A0 true AU2018901056A0 (en) 2018-04-19

Family

ID=

Similar Documents

Publication Publication Date Title
EP3836923A4 (en) Pyrrolo - dipyridine compounds
EP3801265A4 (en) Uroflowmeter
EP3793551A4 (en) Oxadiazole compounds
EP3868764A4 (en) Sting-agonist compound
EP3758057A4 (en) Heatsink
EP3784463A4 (en) Fluorosulfones
EP3808747A4 (en) Imidazopyridinone compound
EP4077318A4 (en) Compounds
EP3728289A4 (en) Optimised compounds
EP3721129A4 (en) Cryosphere
EP4003201A4 (en) Bone-binding compounds
EP3902806A4 (en) Thienopyridinone compounds
EP3870300A4 (en) Novel compounds
EP3693969A4 (en) Stage mechanism
EP3831190A4 (en) Combine
EP3738602A4 (en) Cytocide
AU2018903597A0 (en) Optimised compounds (3)
AU2018901056A0 (en) Optimised compounds (2)
AU2018900975A0 (en) IL-38 variants (2)
AU2018900974A0 (en) IL-38 variants (1)
EP3858823A4 (en) Condensed-cyclic compound
EP3923922A4 (en) Isotopically-stabilized tetronimide compounds
EP3920906A4 (en) Bisphosphonate-linked compounds
AU2018101027A4 (en) PadPay
AU2019902220A0 (en) The EarthAlphaNetwork